70 research outputs found

    A programmable beam shaping system for tailoring the profile of high fluence laser beams

    Get PDF
    Customized spatial light modulators have been designed and fabricated for use as precision beam shaping devices in fusion class laser systems. By inserting this device in a low-fluence relay plane upstream of the amplifier chain, 'blocker' obscurations can be programmed into the beam profile to shadow small isolated flaws on downstream optical components that might otherwise limit the system operating energy. In this two stage system, 1920 x 1080 bitmap images are first imprinted on incoherent, 470 nm address beams via pixilated liquid crystal on silicon (LCoS) modulators. To realize defined masking functions with smooth apodized shapes and no pixelization artifacts, address beam images are projected onto custom fabricated optically-addressable light valves. Each valve consists of a large, single pixel liquid cell in series with a photoconductive Bismuth silicon Oxide (BSO) crystal. The BSO crystal enables bright and dark regions of the address image to locally control the voltage supplied to the liquid crystal layer which in turn modulates the amplitude of the coherent beams at 1053 nm. Valves as large as 24 mm x 36 mm have been fabricated with low wavefront distortion (<0.5 waves) and antireflection coatings for high transmission (>90%) and etalon suppression to avoid spectral and temporal ripple. This device in combination with a flaw inspection system and optic registration strategy represents a new approach for extending the operational lifetime of high fluence laser optics

    Programmable beam spatial shaping system for the National Ignition Facility

    Full text link
    A system of customized spatial light modulators has been installed onto the front end of the laser system at the National Ignition Facility (NIF). The devices are capable of shaping the beam profile at a low-fluence relay plane upstream of the amplifier chain. Their primary function is to introduce 'blocker' obscurations at programmed locations within the beam profile. These obscurations are positioned to shadow small, isolated flaws on downstream optical components that might otherwise limit the system operating energy. The modulators were designed to enable a drop-in retrofit of each of the 48 existing Pre Amplifier Modules (PAMs) without compromising their original performance specifications. This was accomplished by use of transmissive Optically Addressable Light Valves (OALV) based on a Bismuth Silicon Oxide photoconductive layer in series with a twisted nematic liquid crystal (LC) layer. These Programmable Spatial Shaper packages in combination with a flaw inspection system and optic registration strategy have provided a robust approach for extending the operational lifetime of high fluence laser optics on NIF

    Demonstration of Ignition Radiation Temperatures in Indirect-Drive Inertial Confinement Fusion Hohlraums

    Full text link

    Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment

    Get PDF

    Lawson criterion for ignition exceeded in an inertial fusion experiment

    Get PDF
    For more than half a century, researchers around the world have been engaged in attempts to achieve fusion ignition as a proof of principle of various fusion concepts. Following the Lawson criterion, an ignited plasma is one where the fusion heating power is high enough to overcome all the physical processes that cool the fusion plasma, creating a positive thermodynamic feedback loop with rapidly increasing temperature. In inertially confined fusion, ignition is a state where the fusion plasma can begin "burn propagation" into surrounding cold fuel, enabling the possibility of high energy gain. While "scientific breakeven" (i.e., unity target gain) has not yet been achieved (here target gain is 0.72, 1.37 MJ of fusion for 1.92 MJ of laser energy), this Letter reports the first controlled fusion experiment, using laser indirect drive, on the National Ignition Facility to produce capsule gain (here 5.8) and reach ignition by nine different formulations of the Lawson criterion

    Cryogenic thermonuclear fuel implosions on the National Ignition Facility

    Full text link

    Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

    Get PDF
    BACKGROUND: Limited information is available for patients with breast cancer (BC) and coronavirus disease 2019 (COVID-19), especially among underrepresented racial/ethnic populations. METHODS: This is a COVID-19 and Cancer Consortium (CCC19) registry-based retrospective cohort study of females with active or history of BC and laboratory-confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection diagnosed between March 2020 and June 2021 in the US. Primary outcome was COVID-19 severity measured on a five-level ordinal scale, including none of the following complications, hospitalization, intensive care unit admission, mechanical ventilation, and all-cause mortality. Multivariable ordinal logistic regression model identified characteristics associated with COVID-19 severity. RESULTS: 1383 female patient records with BC and COVID-19 were included in the analysis, the median age was 61 years, and median follow-up was 90 days. Multivariable analysis revealed higher odds of COVID-19 severity for older age (aOR per decade, 1.48 [95% CI, 1.32-1.67]); Black patients (aOR 1.74; 95 CI 1.24-2.45), Asian Americans and Pacific Islander patients (aOR 3.40; 95 CI 1.70-6.79) and Other (aOR 2.97; 95 CI 1.71-5.17) racial/ethnic groups; worse ECOG performance status (ECOG PS ≥2: aOR, 7.78 [95% CI, 4.83-12.5]); pre-existing cardiovascular (aOR, 2.26 [95% CI, 1.63-3.15])/pulmonary comorbidities (aOR, 1.65 [95% CI, 1.20-2.29]); diabetes mellitus (aOR, 2.25 [95% CI, 1.66-3.04]); and active and progressing cancer (aOR, 12.5 [95% CI, 6.89-22.6]). Hispanic ethnicity, timing, and type of anti-cancer therapy modalities were not significantly associated with worse COVID-19 outcomes. The total all-cause mortality and hospitalization rate for the entire cohort was 9% and 37%, respectively however, it varied according to the BC disease status. CONCLUSIONS: Using one of the largest registries on cancer and COVID-19, we identified patient and BC-related factors associated with worse COVID-19 outcomes. After adjusting for baseline characteristics, underrepresented racial/ethnic patients experienced worse outcomes compared to non-Hispanic White patients. FUNDING: This study was partly supported by National Cancer Institute grant number P30 CA068485 to Tianyi Sun, Sanjay Mishra, Benjamin French, Jeremy L Warner; P30-CA046592 to Christopher R Friese; P30 CA023100 for Rana R McKay; P30-CA054174 for Pankil K Shah and Dimpy P Shah; KL2 TR002646 for Pankil Shah and the American Cancer Society and Hope Foundation for Cancer Research (MRSG-16-152-01-CCE) and P30-CA054174 for Dimpy P Shah. REDCap is developed and supported by Vanderbilt Institute for Clinical and Translational Research grant support (UL1 TR000445 from NCATS/NIH). The funding sources had no role in the writing of the manuscript or the decision to submit it for publication. CLINICAL TRIAL NUMBER: CCC19 registry is registered on ClinicalTrials.gov, NCT04354701

    Progress towards ignition on the National Ignition Facility

    Full text link
    corecore